Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Western Medicine and Class B Patent Medicines	222.03M	130.70M	117.87M
Western Medicine and Class B Patent Medicines Growth	69.88%	10.89%	-
Total	222.03M	130.70M	117.87M
Total Growth	69.88%	10.89%	-

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Taiwan	222.03M	130.70M	117.87M
Taiwan Growth	69.88%	10.89%	-
Total	222.03M	130.70M	117.87M
Total Growth	69.88%	10.89%	-

Source: S&P Global Market Intelligence.